title: The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X.
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Russell
authors.forename: Eugenie M
authors.initials: EM
authors.lastname: Di Stefano
authors.forename: Mahmud T
authors.initials: MT
authors.lastname: Naffati
authors.forename: Oliver
authors.initials: O
authors.lastname: Brown
authors.forename: Stephen
authors.initials: S
authors.lastname: Saltissi
mesh_terms: D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D000077405:Irbesartan; D008297:Male; D017566:Microvascular Angina / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan